{"symbol":"BSX","fiscalQuarter":"Q4-2019","reportDate":"2020-02-05","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q4-2019","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Down 0.61%","keyNumbers":[{"metric":"EPS","actual":"$0.46","expected":"N/A","surprise":"+1.10%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation and product development.","They expressed confidence in their long-term growth strategy despite current market challenges."],"summary":"Management remains focused on driving growth through innovation. They acknowledged challenges but emphasized their commitment to long-term objectives."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a slight beat on EPS, which is a positive sign for the company. However, the stock reacted negatively, declining by 0.61%. This could indicate investor caution despite the earnings beat, possibly due to the lack of revenue data and forward guidance.","metaDescription":"Boston Scientific (BSX) Q4 2019 earnings: EPS beat by 1.10%. Stock down 0.61%. Full breakdown."}}